Drug profile · INN
trofinetide
DAYBU
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
trofinetide (DAYBU) is an FDA-listed pharmaceutical active ingredient. Associated with Acadia Pharmaceuticals B.V.. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN trofinetide
Brand DAYBU
Route ORAL
Formulation SOLUTION
ATC code N07XX
Originator Acadia Pharmaceuticals B.V.
Related patents
Search patents →Frequently asked questions
What is trofinetide?
trofinetide (DAYBU) is an FDA-listed pharmaceutical active ingredient. Associated with Acadia Pharmaceuticals B.V.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trofinetide?
DAYBU is a marketed brand name for trofinetide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trofinetide?
trofinetide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.